Company Directory / biotechnology
PrivateFor profitbiotechnologyHayward, United States
Rondo Therapeutics
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
- Founded
- 2019 7 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $67M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
7 years old.
Reach
Website ranked #9,025,389 in the world for traffic, about 445 visits a month.
What it does
BiopharmaBiotechnologyHealth CareLife Science
Funding, as listed
$67M currency not stated
- Rounds1
- LatestSeries a, Mar 2022
- Investors5, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Rondo Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Rondo Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2019
- Founders
- Nathan Trinklein, Shelley Force Aldred
- Industry
- biotechnology
- Categories
- Biopharma, Biotechnology, Health Care, Life Science
Where
- City
- Hayward
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #9,025,389
- Monthly web visits
- 445
Funding, as listed
- Total
- 67,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Series a
- Latest round date
- Mar 2022
- Investors
- 5
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
biotechnology in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.